in next event of seminar series
The Yale BioHaven Entrepreneurship Seminar series continues on Tuesday, March 14, with a look at VaxInnate, a local technology start-up company that is exploiting the principles of innate immunity to provide the next generation of vaccines and immune therapies for infectious diseases.
The seminar will take place 4-5 p.m. in the School of Medicine's Anlyan Center auditorium, 300 Cedar St.
Speakers will be Jeff Powell, vice president of research at VaxInnate, and Ruslan M. Medzhitov, scientific co-founder of VaxInnate, professor of immunobiology at Yale and a Howard Hughes Medical Institute investigator.
The innate immune system alerts the host to an infectious assault and triggers a cascade of responses -- known as the adaptive immune response -- that is the basis for vaccine activity. Recent evidence indicates that more potent and selective vaccines can be developed by presenting the immune system with disease antigens that are physically linked to particular polypeptide activators of the innate immune response.
VaxInnate is developing a high-throughput screening platform to identify these activators of the innate immune response and to incorporate them into vaccine development for influenza, flaviviruses and other infectious diseases, as well as immune therapies for cancer.
Founded in 2001, VaxInnate has research facilities located at 300 George St. in New Haven. The company completed a $23.1 million Series B round of financing in December of 2003, and was awarded $5.9 million in June of 2004, by the National Institutes of Allergy & Infectious Disease. Further information on VaxInnate is available at www.vaxinnate.com online.
The seminar will be followed by refreshments and time for networking. Registration is free, but required. To register, contact Lucy Sargeant at lucy.sargeant@yale.edu or call the Yale Office of Cooperative Research at (203) 436-8096.
Yale BioHaven Entrepreneurship Seminars are sponsored jointly by the Office of Cooperative Research, Connecticut United for Research Excellence, the Yale Entrepreneurial Society and the Yale Biotechnology & Pharmaceutical Society.
T H I S
W E E K ' SS T O R I E S
Noted critic and artist Robert Storr named next dean of School of Art
Two faculty receive prestigious prizes
Joseph Roach wins Mellon Award for studies on world performance
Joseph Schlessinger gets David Prize for work on cancer treatmentBrothers' gift to renovate site of their former athletic glory
Yale licenses ovarian cancer test technology to LabCorp
Gallery acquires rare painting by Yale-educated artist
Yale donates important set of books to the British Parliament
ENDOWED PROFESSORSHIPS
Richard Casten is named D. Allan Bromley Professor
Peter Swenson is new Charlotte Marion Saden ProfessorWilliam Clyde DeVane Medals are awarded to two scientists
Ignorance of world news could imperil the nation, says journalist
Event explored 'Youth and the Future of U.S.-Islamic Relations'
Doll exhibition marks Japanese celebration of 'Girls Day'
Museum hosting talk on Connecticut day trips, annual 'Fiesta Latina'
Chinese Christian art is featured in Institute of Sacred Music exhibit
Study suggests people may learn best on an empty stomach
VaxInnate officials to speak in next event of seminar serie
Volunteers sought for Ob/Gyn's Kronos Early Estrogen Prevention Study
Competition aims to educate campuses nationwide about recycling
Yale Books in Brief
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home